Form 4: Camp4 Therapeutics Director and 10% Owner Acquires 9,000 Stock Options

Amir Nashat, a Director and 10% owner of Camp4 Therapeutics Corp, acquired 9,000 stock options with an exercise price of $1.56, vesting on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders.

Summary

• Amir Nashat, who serves as a Director and 10% owner of Camp4 Therapeutics Corp (CAMP), acquired 9,000 stock options.
• The acquired stock options have an exercise price of $1.56 per share.
• The transaction date for this acquisition was June 25, 2025.
• These options are set to expire on June 24, 2035.
• The shares underlying the option will vest in their entirety on the earlier of the first anniversary of the grant date (June 25, 2025) or the date of the issuer's next annual meeting of stockholders, contingent upon Mr. Nashat's continued service to the issuer's board of directors through the applicable vesting date.
• Following this reported transaction, Mr. Nashat directly beneficially owns 9,000 derivative securities.

Sentiment

Score: 6

Explanation: The acquisition of stock options by a director and 10% owner can be interpreted as a positive signal of confidence in the company's future, though the filing itself is a routine disclosure of an equity compensation event.

Positives

• A Director and 10% owner, Amir Nashat, acquired 9,000 stock options, which may signal confidence in the company's future performance and alignment of interests with shareholders.

Risks

• The value of the acquired stock options is contingent on the future market price of Camp4 Therapeutics Corp's common stock exceeding the exercise price of $1.56 per share.

Future Outlook

The vesting schedule of the acquired stock options is tied to continued service to the issuer's board of directors, indicating an expectation of ongoing involvement and commitment from the reporting person.

Industry Context

This filing is a standard disclosure of insider equity transactions, common across all publicly traded companies, and does not directly reflect broader industry trends. It indicates an insider's personal investment activity in the company.

Related Party Transactions

• The grant of stock options to Amir Nashat, a Director and 10% owner, represents a transaction between the company and a related party as part of his compensation package.

Stakeholder Impact

• Shareholders: The acquisition of options by an insider may be viewed positively as a sign of management confidence in the company's future prospects. However, the potential future exercise of these options could lead to minor dilution of existing shares.

Next Steps

• The acquired stock options will vest on the earlier of June 25, 2026 (first anniversary of grant date) or the date of the issuer's next annual meeting of stockholders, subject to continued service.
• The reporting person may exercise the options at any time after vesting until their expiration date of June 24, 2035.

Key Dates

Keywords

Camp4 Therapeutics, CAMP, Stock Option, Insider Transaction, Form 4, Beneficial Ownership, Director, 10% Owner, Equity Compensation